DILH
ARIA

Dai-ichi Life Holdings’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Dai-ichi Life Holdings’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-64,054
Closed -$877K – 546
2016
Q3 		$877K Buy
+64,054
New +$643K 0.03% 418

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Dai-ichi Life Holdings's ARIA Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2016, closing a stake of 64,054 shares — an estimated $877K sold.

Dai-ichi Life Holdings first reported a position in ARIA in Q3 2016 and held it in 1 quarter. The position peaked at $877K in Q3 2016. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 64,054 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $877K.
  • Dai-ichi Life Holdings first reported a position in Ariad Pharmaceuticals Inc in Q3 2016 and held it in 1 quarter.
  • Dai-ichi Life Holdings's Ariad Pharmaceuticals Inc position peaked at $877K in Q3 2016.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.